🇺🇸 Ceftazidime Injection in United States
16 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 16
Most-reported reactions
- Cardio-Respiratory Arrest — 2 reports (12.5%)
- Clostridium Test Positive — 2 reports (12.5%)
- Fungal Infection — 2 reports (12.5%)
- Heart Rate Increased — 2 reports (12.5%)
- Pneumonia — 2 reports (12.5%)
- Respiratory Distress — 2 reports (12.5%)
- Altered State Of Consciousness — 1 report (6.25%)
- Arrhythmia — 1 report (6.25%)
- Blood Culture Positive — 1 report (6.25%)
- Blood Pressure Decreased — 1 report (6.25%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Ceftazidime Injection approved in United States?
Ceftazidime Injection does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Ceftazidime Injection in United States?
Murdoch Childrens Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.